title: Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment.
authors.forename: Solange Oliveira Rodrigues
authors.initials: SO
authors.lastname: do Valle
authors.forename: Alfeu Tavares
authors.initials: AT
authors.lastname: França
authors.forename: Gisele Vian
authors.initials: GV
authors.lastname: Pires
authors.forename: Patrícia
authors.initials: P
authors.lastname: Guimarães
authors.forename: Gabriela Andrade Coelho
authors.initials: GA
authors.lastname: Dias
authors.forename: Solony Afra Pires
authors.initials: SA
authors.lastname: Levy
mesh_terms: D000328:Adult; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects*; D003715:Dengue / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D004890:Erythema; D005260:Female; D005334:Fever; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D006919:Hydroxyzine / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011537:Pruritus; D011899:Ranitidine / Q000008:administration & dosage; D014581:Urticaria
chemical_list: D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D006919:Hydroxyzine; D011899:Ranitidine; D003622:Dapsone; D011241:Prednisone